Using the BROCA Genetic Assay to Treat Breast Cancer

Jane E. Churpek, MD, describes the BROCA genetic assay, uses targeted genomic capture and next-generation sequencing to analyze a panel of 42 genes.

Jane E. Churpek, MD, medical oncologist, hematologist, The University of Chicago, describes the BROCA genetic assay.

The BROCA assay uses new tools called targeted genomic capture and next-generation sequencing to analyze a panel of 42 genes. Of those 42 genes, 18 are breast cancer susceptibility genes, including BRCA 1 and BRCA 2.